Denali Therapeutics Inc. (DNLI) revenue

Revenue · fiscal 2023
$330.53M

Denali Therapeutics Inc. (DNLI) reported revenue of $330.53M in fiscal 2023 (the year ended December 31, 2023). That is 204.7% higher than the $108.46M of fiscal 2022. Figures as of 18 Nov 2026, 10:36 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2023
$330.53M
Change on fiscal 2022
+204.7%
Growth, 5 years
+20.7% a year
Highest on record
$335.56Mfiscal 2020
Lowest on record
$26.32Mfiscal 2019
Fiscal years on record
62018–2023

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Denali Therapeutics Inc. revenue, in more detail

Over the five fiscal years to 2023 revenue grew at a compound 20.7% a year. Across the 6 fiscal years on record (2018–2023), the highest was $335.56M in fiscal 2020 and the lowest $26.32M in fiscal 2019.

History · 6 fiscal years

Revenue by fiscal year

Denali Therapeutics Inc. revenue, year by year

Denali Therapeutics Inc. (DNLI) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2023$330.53M 204.7% up
2022$108.46M 122.9% up
2021$48.66M 85.5% down
2020$335.56M 1,174.9% up
2019$26.32M 79.6% down
2018$129.10M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on DNLI

Denali Therapeutics Inc., figure by figure

Denali Therapeutics Inc. (DNLI) overview: price, valuation and scorecard

Denali Therapeutics Inc. revenue: questions and answers

What is Denali Therapeutics Inc.'s revenue?

Denali Therapeutics Inc. (DNLI) reported revenue of $330.53M in fiscal 2023 (the year ended December 31, 2023). That is 204.7% higher than the $108.46M of fiscal 2022.

What is the growth rate of Denali Therapeutics Inc.'s revenue?

Over the five fiscal years to 2023 revenue grew at a compound 20.7% a year.

What are the highest and lowest revenue figures on record for Denali Therapeutics Inc.?

Across the 6 fiscal years on record (2018–2023), the highest was $335.56M in fiscal 2020 and the lowest $26.32M in fiscal 2019.

How is Denali Therapeutics Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Denali Therapeutics Inc. it is on record here for 6 fiscal years, 2018 to 2023.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Denali Therapeutics Inc. (DNLI) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/DNLI/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.